noscript

News and Announcements

Proteomics PromarkerD Update

  • Published March 07, 2016 12:50PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

7th March 2016, ASX Announcement

Highlights:

  • Follow up, validation study on 500 patient cohort underway – results to be announced in due course.
  • Company is instigating its own development program to produce a standard clinical pathology In vitro Diagnostic (IVD) test kit for PromarkerD.
  • PILL to present to key bio-analytical sector decision markers at invitation only events in the USA this week.

Life sciences company Proteomics International Laboratories Ltd (ASX: PIQ) (the Company, PILL) is pleased to provide the following market update on PromarkerD, the world’s first proteomics-derived predictive (prognostic) test for the diagnosis of Diabetic Kidney Disease.

Partnering and Licensing Progress 

PILL remains in ongoing discussions with a number of diagnostic and pharmaceutical companies in global markets, including USA, Europe, Japan and Latin America, for the commercialisation of PromarkerD. As part of this process, PILL has been in discussion with a major global health care company (potential partner) for a period of 11 months in relation to the partnering and licencing of PromarkerD. These discussions continue to progress in a positive manner.

To view the full announcement, please click here

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now